470 related articles for article (PubMed ID: 30666839)
1. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
Liu W; Zhou Z; Dong D; Sun L; Zhang G
Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
[TBL] [Abstract][Full Text] [Related]
2. Association between lymphovascular invasion and oncologic outcomes among upper urinary tract urothelial carcinoma patients who underwent radical nephroureterectomy.
Song SH; Ye CH; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2863-2870. PubMed ID: 31501983
[TBL] [Abstract][Full Text] [Related]
3. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
5. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location.
Lee HY; Li CC; Huang CN; Ke HL; Li WM; Liang PI; Yang SF; Tu HP; Wu WJ; Yeh HC
Ann Surg Oncol; 2015 Apr; 22(4):1392-400. PubMed ID: 25239005
[TBL] [Abstract][Full Text] [Related]
9. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
10. Effects of Variant Histology on the Oncologic Outcomes of Patients With Upper Urinary Tract Carcinoma After Radical Nephroureterectomy: A Propensity Score-Matched Analysis.
Chung HS; Hwang EC; Kim MS; Yu SH; Jung SI; Kang TW; Choi C; Choi SH; Kwon TG; Noh JH; Kim MK; Cho WJ; Kang SG; Kang SH; Cheon J; Seo IY; Chung H; Kim HS; Lee CH; Ku JY; Ha HK; Kim BH; Jeong CW; Ku JH; Kwak C; Kwon D
Clin Genitourin Cancer; 2019 Jun; 17(3):e394-e407. PubMed ID: 30782419
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tumor multifocality on outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy: A cohort study.
Milojevic B; Bumbasirevic U; Santric V; Kajmakovic B; Dragicevic D; Radisavcevic D; Sretenovic M; Grujicic SS
Curr Probl Cancer; 2021 Dec; 45(6):100747. PubMed ID: 33883080
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
[TBL] [Abstract][Full Text] [Related]
13. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy.
Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK
Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
[TBL] [Abstract][Full Text] [Related]
16. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.
Novara G; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Bastian PJ; Martínez-Salamanca JI; Seitz C; Lemberger RJ; Burger M; El-Hakim A; Baba S; Martignoni G; Gupta A; Karakiewicz PI; Ficarra V; Shariat SF
Eur Urol; 2010 Jun; 57(6):1064-71. PubMed ID: 20071073
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
19. Influence of positive surgical margin status after radical nephroureterectomy on upper urinary tract urothelial carcinoma survival.
Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot de Treigny O; Laurent G; Valeri A; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Rouprêt M
Ann Surg Oncol; 2012 Oct; 19(11):3613-20. PubMed ID: 22843187
[TBL] [Abstract][Full Text] [Related]
20. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]